Galderma (PK)【GDERF】銘柄情報

Galderma Group AG (PK) (GDERF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

219.40

( -3.48% )

買値

211.20

売値

230.60

出来高

102

平均取引量 (3 か月)

US$ 486,174

財務取引量

US$ 22,523

219.40 日の範囲 229.85

150.00 52 週間の範囲 248.46

時価総額

51.464B

企業価値

54.398B

前日終値

227.30

始値

222.00

時刻

219.4

最終取引時間

02:50:24

VWAP

220.8123

歳入

5.24B

純利益

613M

発行済株式数

234,568,725

浮動株比率 (%)

56.55%

機関投資家保有比率 (%)

54.90%

配当利回り

0.44

PER

86.62

株価売上高倍率 (PSR)

1 株当たり利益 (EPS)

2.58

ベータ

-0.08

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ... Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland. 詳細を表示

セクター

業界

ウェブサイト

www.galderma.com

本社

Zug, Switzerland

設立

1981

Galderma Group AG (PK) is listed in the sector of the その他OTC with ticker GDERF. The last closing price for Galderma (PK) was US$227.30. Over the last year, Galderma (PK) shares have traded in a share price range of US$ 150.00 to US$ 248.46.

Galderma (PK) currently has 234,568,725 shares in issue. The market capitalisation of Galderma (PK) is US$51.46 billion. Galderma (PK) has a price to earnings ratio (PE ratio) of 86.62.

A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill It

A $190 Billion Weight-Loss Boom Exposed a Tissue-Restoration Gap, and One Nasdaq Company Is Moving to Fill...

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ: CNXU) opened a new research and...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-17.9	-7.54319426886	237.3	238.05	213.9	350	227.9092381	CS
4	16.15	7.94587945879	203.25	245.97	201.75	1758	207.77648482	CS
12	13.05	6.32420644536	206.35	248.46	175.11	853	205.44909963	CS
26	9.204	4.37877029059	210.196	248.46	172.75	900	200.02189855	CS
52	69.4	46.2666666667	150	248.46	150	981	191.16046106	CS
156	142.29	184.528595513	77.11	248.46	76.5463	977	176.05000667	CS
260	142.29	184.528595513	77.11	248.46	76.5463	977	176.05000667	CS